Advertisement

Result of a Cooperative Study with L-Asparaginase in Human Leukemias

Report of the Section “Oncology” of the Paul-Ehrlich-Society for Chemotherapy
  • H. Gerhartz
  • H. Begemann
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 33)

Abstract

Through the Paul-Ehrlich-Society for Chemotherapy, clinical trials of L-asparaginase 1 were conducted in three different programs (Table 1): First, in an orientation trial, an attempt was made to treat all cases of acute leukemias at a constant dose of 200 IU/kg daily intravenously for a period of 4 weeks.

Keywords

Complete Remission Acute Lymphoblastic Leukemia Lymphoblastic Leukemia Acute Leukemia Acute Promyelocytic Leukemia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag Berlin • Heidelberg 1970

Authors and Affiliations

  • H. Gerhartz
    • 1
  • H. Begemann
    • 1
  1. 1.Hämat.-onkol. Abt. Med. Klinik Westend Freien Universität Berlin u. Med. KlinikKrankenhaus München-SchwabingGermany

Personalised recommendations